dc.contributor.author |
Seni, Jeremiah
|
|
dc.contributor.author |
Peirano, Gisele
|
|
dc.contributor.author |
Okon, Kenneth Okwong
|
|
dc.contributor.author |
Jibrin, Yusuf Bara
|
|
dc.contributor.author |
Mohammed, Alkali
|
|
dc.contributor.author |
Mshana, Stephen E.
|
|
dc.contributor.author |
DeVinney, Rebekah
|
|
dc.contributor.author |
Pitout, Johann D.D.
|
|
dc.date.accessioned |
2018-06-25T06:02:49Z |
|
dc.date.issued |
2018-09 |
|
dc.description.abstract |
Limited information is available regarding the population structure of extra-intestinal pathogenic Escherichia coli (ExPEC) in Africa. Antimicrobial resistance profiles, sequence types (STs) and fimH types were determined on 60 clinical ExPEC from Nigeria using a 7-single nucleotide polymorphism quantitative PCR and sequencing of certain genes. Different ST131 clades were identified with a multiplex PCR. The isolates were mostly obtained from urines (58.3%). Not-susceptibility rates were as follows: trimethoprim-sulfamethoxazole (98%), cefotaxime (68%), gentamicin (55%), ciprofloxacin (62%) and piperacillin-tazobactam (2%). Dominant STs were associated with CTX-M-15 and included ST131-fimH30 (23%), ST457-fimH145 (20%), ST405-fimH27 (13%) and ST95-fimH41 (10%). We found the 7-SNP qPCR to be simple and cost-effective that can be utilized to tract different ExPEC clones on a global scale. This study provided insight into the population structure of ExPEC from Nigeria showing high prevalence of the rarely reported ST457 and the presence of multidrug resistant ST95. |
en_ZA |
dc.description.department |
Medical Microbiology |
en_ZA |
dc.description.embargo |
2019-09-01 |
|
dc.description.librarian |
hj2018 |
en_ZA |
dc.description.sponsorship |
The University of Calgary (UCRG Seed Grant) to RD and a research grant from the Calgary Laboratory Services (#10015169) to JDDP. |
en_ZA |
dc.description.uri |
http://www.elsevier.com/locate/diagmicrobio |
en_ZA |
dc.identifier.citation |
Seni, J., Peirano, G., Okon, K.O. et al. 2018, 'The population structure of clinical extra-intestinal Escherichia coli in a teaching hospital from Nigeria', Diagnostic Microbiology and Infectious Disease, vol. 92, no. 1, pp. 46-49. |
en_ZA |
dc.identifier.issn |
0732-8893 (print) |
|
dc.identifier.issn |
1879-0070 (online) |
|
dc.identifier.other |
10.1016/j.diagmicrobio.2018.04.001 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/65222 |
|
dc.language.iso |
en |
en_ZA |
dc.publisher |
Elsevier |
en_ZA |
dc.rights |
© 2018 Elsevier Inc. All rights reserved. Notice : this is the author’s version of a work that was accepted for publication in Diagnostic Microbiology and Infectious Diseases. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Diagnostic Microbiology and Infectious Diseases, vol. 92, no. 1, pp. 46-49, 2018. doi : 10.1016/j.diagmicrobio.2018.04.001. |
en_ZA |
dc.subject |
Escherichia coli |
en_ZA |
dc.subject |
Population structure |
en_ZA |
dc.subject |
Molecular typing |
en_ZA |
dc.subject |
Nigeria |
en_ZA |
dc.subject |
Nucleotide |
en_ZA |
dc.subject |
Polymerase chain reaction (PCR) |
en_ZA |
dc.subject |
Antimicrobial |
en_ZA |
dc.subject |
Trimethoprim-sulfamethoxazole |
en_ZA |
dc.subject |
Gentamicin |
en_ZA |
dc.subject |
Piperacillin-tazobactam |
en_ZA |
dc.subject |
Ciprofloxacin |
en_ZA |
dc.subject |
Cefotaxime |
en_ZA |
dc.subject |
Bloodstream infections |
en_ZA |
dc.subject |
Gram-negative bacterium |
en_ZA |
dc.title |
The population structure of clinical extra-intestinal Escherichia coli in a teaching hospital from Nigeria |
en_ZA |
dc.type |
Postprint Article |
en_ZA |